Clinical Trial Update: Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated first-line therapy with paclitaxel and carboplatin with or without sorafenib in ovarian cancer; the study completed and results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Carboplatin (Paraplatin) (carboplatin)
• Paclitaxel (Taxol) (paclitaxel)
• Sorafenib (Nexavar) (Sorafenib)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-12-22